Quick Takeaways
- This page summarizes Michael Patrick Miller's Form 4 filing for BioXcel Therapeutics, Inc. (BTAI).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 28 Jun 2023, 16:59.
Michael Patrick Miller - 26 Jun 2023 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)
- Role
- Director
- Signature
- /s/ Richard I. Steinhart, Attorney-in-Fact for Michael Miller
- Issuer symbol
- BTAI
- Transactions as of
- 26 Jun 2023
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 28 Jun 2023, 16:59:51 UTC
- Previous filing
- 15 Jun 2023
- Next filing
- 09 Nov 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael Patrick Miller filed Form 4 for BioXcel Therapeutics, Inc. (BTAI) on 28 Jun 2023."
What Changed
- Previous filing in this sequence was filed on 15 Jun 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BTAI | Stock Option (Right to Buy) | Award | $0 | +17,000 | $0.000000 | 17,000 | 26 Jun 2023 | Common Stock | 17,000 | $17.52 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. |